Created by Johns Hopkins researchers, EpiScalp could significantly reduce false positives and spare patients from medication side effects, driving restrictions, and other quality-of-life challenges ...
Second Clinical Trial Getting Underway for PathMaker’s Non-Invasive ALS Treatment PlatformBOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (“PathMaker”), a clinical-stage neuromodulation company developing ...